Nivolumab Immunotherapy in Malignant Mesothelioma: A Case Report Highlighting a New Opportunity for Exceptional Outcomes

Riley G. Jones; Felix Karthik; Anushree Dugar; Karthik Kanagarajan; Kalpan Desai; Manish Bhandari

doi:10.12659/AJCR.909584

04 July 2018 : Case report USA

Nivolumab Immunotherapy in Malignant Mesothelioma: A Case Report Highlighting a New Opportunity for Exceptional Outcomes

Unusual or unexpected effect of treatment, Unexpected drug reaction, Rare disease

Riley G. Jones^12ABCDEFG*, Felix Karthik^3EF, Anushree Dugar^4EF, Karthik Kanagarajan^3DEFG, Kalpan Desai^5ABCDEFG, Manish Bhandari^4ABCDEFG

DOI: 10.12659/AJCR.909584

Am J Case Rep 2018; 19:783-789

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

Export

Export Article Citation

Share via email

Share method:

Via email client program

Send me to my email

Content:

Title, authors, link

Title, authors, link, abstract

Nivolumab Immunotherapy in Malignant Mesothelioma: A Case Report Highlighting a New Opportunity for Exceptional Outcomes

Export

Export Article Citation

Export file: The selected type of file is required

Content:

Share via email

Share method:

Content:

Preview:

Your Privacy